发明名称 |
COMPUESTOS DERIVADOS DE 2,3-DIHIDROIMIDAZOL[1,2-C]QUINAZOLINA; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHOS COMPUESTOS; Y SU USO PARA TRATAR ENFERMEDADES Y TRASTORNOS HIPERPROLIFERATIVOS ASOCIADOS A LA ANGIOGENESIS, TALES COMO INFLAMACION, ENFERME |
摘要 |
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. |
申请公布号 |
CL2007003508(A1) |
申请公布日期 |
2008.07.04 |
申请号 |
CL20070003508 |
申请日期 |
2007.12.05 |
申请人 |
BAYER PHARMACEUTICALS CORPORATION, SOCIEDAD ANONIMA ORGANIZADA BAJO LAS LEYES DEL ESTADO DE DELAWARE |
发明人 |
MARTIN HENTEMANN, JILL WOOD, WILLIAM SCOTT, ANN-MARIE CAMPBELL, ANN-MARIE BULLION, R. BRUCE ROWLEY,ANIKO REDMAN, MARTIN |
分类号 |
A61K31/4745;A61P25/00;A61P35/00;C07D487/04 |
主分类号 |
A61K31/4745 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|